Sandoz is recalling approximately 636,000 bottles of Losartan Potassium and Ezetimibe prescription medications because the packaging is not child-resistant. This recall affects Ezetimibe 10mg tablets (30 and 90-count bottles) and Losartan Potassium 50mg tablets (30-count bottles) sold at clinics and pharmacies nationwide from July 2018 through August 2019. Consumers should immediately secure these medications away from children and contact Sandoz for a free replacement child-resistant cap. While waiting for the replacement cap, the medication can continue to be used as directed provided it is kept in a secure location.
The drug packaging fails to meet the requirements of the Poison Prevention Packaging Act, creating a risk of accidental poisoning if children are able to open the bottles and swallow the medication. No injuries have been reported to date.
Consumers should immediately secure the medications to keep them out of the sight and reach of children and contact Sandoz for a free replacement child resistant bottle cap. Once the medication is secured, consumers can continue to use the medication as directed.
Ezetimibe 10mg Tablets 30 count bottle
Ezetimibe 10mg Tablets 90 count bottle
Losartan Potassium 50mg Tablets 30 count bottle
Lot and Expiration Date Location
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: CPSC Notice · Raw API Response